0

Your Cart is Empty

CBG Oil Vs. CBD Oil: What'S The Difference?

August 17, 2022 5 min read

CBG Oil Vs. CBD Oil: What'S The Difference?

CBG Oil Vs. CBD Oil: What'S The Difference?

Some people fail to differentiate between CBD oil from CBG. This article gives all the differences between the two, including; what CBG is, the difference between CBG and CBD oil, and its benefits.

Cannabigerol (CBG) and cannabidiol (CBD) are two of the cannabinoid chemicals found in the hemp plant (Cannabis Sativa plant). Much attention has been paid to cannabidiol (CBD) oil, one of more than 100 cannabinoids in cannabis. When utilizing a high-quality CBD product like those supplied by CBD One, a frequent misconception is that you are just using CBD. You use a complex blend of other cannabinoids, terpenes, and flavonoids.

It is correct to refer to these items as "cannabis extracts" since one can only achieve this effect by utilizing a full spectrum plant extract. Much more powerful and effective than CBD isolate-based products. The synergistic impact of cannabis's many components is maximized when using a broad-spectrum product. Terpenes provide flavor and have fascinating effects like soothing or mood-elevating, while flavonoids, though little understood, give depth to the color and taste. Cannabinoids affect your ECS (endocannabinoid system) and other qualities. We also know that they have anti-inflammatory effects, and it seems that they contribute to the potency of cannabis. Therefore, the potency of the natural plant is lost if you have a CBD product that is very transparent (I have seen ones that are as clear as water). Despite their slick packaging and labels, most cannabis products on the market cannot compare to the potency of a complete plant extract. Anybody using CBD, a premium cannabis extract, will also be consuming legal amounts of CBG and all the other beneficial compounds in the plant.

What is CBG?

CBG is an abbreviation for cannabigerol. Originally discovered in 1964, cannabigerol was only one of more than 120 cannabinoids in cannabis. However, research on CBG is few; those that do exist show that it has significant therapeutic potential. According to Anand et al.(2022), CBG may have stronger analgesic effects than THC without the psychoactive high. There is evidence that CBG has antimicrobial, anti-depressant, and anti-cancer properties. In a molecular sense, all of the well-known cannabinoids may be traced back to cannabigerol acid (CBGA). Enzymes in the cannabis plant break down CBGA into the three main cannabinoid acids as the plant develops and matures: cannabidiolic acid (CBDA), tetrahydrocannabinol acid (THCA), and CBCA (cannabichromene acid). Decarboxylation of CBGA yields CBG, which binds to cannabinoid receptors in the body. Navarro et al.(2018) discovered that CBG has some affinity for the cannabinoid receptors CB1 and CB2. Nilius et al.(2012) noted that CBG might activate the receptors that regulate inflammation, heat sensitivity, and pain. CBG may have some affinity for both the CB1 and CB2 receptors. Selective breeding has led to the development of strains that contain much more of this compound, although most cannabis plants naturally contain some CBG. Type IV cannabis refers to strains that are particularly high in cannabigerol. Cannabigerol-dominant plants are being developed on a massive scale, although they aren't yet widely available in the consumer cannabis and hemp markets. Higher concentrations will simplify CBG extraction for medical purposes.

CBD

Cannabidiol, or CBD, is a cannabinoid especially abundant in cannabis and hemp of types II (THC/CBD dominant) and III (CBD dominant). In the late 1930s, CBD was extracted from cannabis, but it wasn't until the 1970s that scientists became interested in it because of its potential anticonvulsant effects. The abbreviation CBD refers to cannabidiol, a component of cannabis that does not produce intoxication. Devinsky et al. (2014) discovered that t highly pure CBD is an effective therapy for severe types of infantile epilepsy. The study above also noted that CBD could reduce inflammation and pain, alleviate nausea and anxiety, and induce sleep. CBD has been more popular in recent years because of its impressive list of medical uses. According to Greydanus et al.(2013), CBD has shown promise for mitigating the negative effects of THC, including anxiety, paranoia, and brain fog. The study above also stated that the entourage effect refers to the synergistic effects of CBD and THC being greater than those of either cannabinoid used alone. CBD affects the endocannabinoid system in a wide variety of ways. It partially binds to CB1 and CB2 receptors and additional receptors in the endocannabinoid system. Its physiological effects are little known.

CBD oil and CBD oil differences?

However, CBG does not affect the endocannabinoid system cannabinoid receptors (CB1 and CB2) as CBD oil does. CBG uniquely affects the body. It implies that it does not provide the same effects as CBD. It has been hypothesized that CBG may help soothe the nervous system. While the exact medical words for these alterations exist (such as suppression of the sympathetic nervous system), it is helpful to think of CBG as having a soothing effect. Gieringer & Rosenthal (2008) noted that people suffering from nightmares might want to investigate CBG oil since it has been shown to improve sleep quality and produce pleasant dreams. Anandamide, a naturally occurring cannabinoid, also seems to be increased by CBG. According to De Oliveira et al.(2019), Anandamide endogenous cannabinoid improves people's mood. The study above also stated that it aids in maintaining normal levels of vital health-related characteristics, including mood, sleep, and hunger. One common genetic characteristic among cheerful individuals is the ability to prevent the breakdown of anandamide, which contributes to their ability to maintain their happiness over time. People consume a cannabis-based product known as exogenous since they get them from outside the body. Endogenous cannabinoids are made inside the body. A wonderful combo of CBG and CBD may be worth testing since CBD aids in anandamide's efficiency.

Can CBG and CBD oils be combined?

A p[erson may take both together since the "entourage effect" is crucial to the efficacy of any cannabis-based product. It is the powerful and helpful result of the remarkable combination of all the components in cannabis. People lose out on the benefits of what Mother Nature intended when they extract only one cannabinoid from the plant.

Conclusion

CBG seems to be the energetic CBD's soothing counterpart, with mood-boosting and relaxing effects that can't be overlooked. People cannot make any bold promises about the efficacy of their products. Still, they can be certain that they are purchasing the finest CBD product with a natural blend of all the components of the marijuana plant since they are both safe to try and of the highest manufacturing quality. Consider using CBG products if you suffer from sleepless nights and nightmares to help you have sweet dreams.

References

Anand, U., Oldfield, C., Pacchetti, B., Anand, P., & Sodergren, M. H. (2021). Dose-Related Inhibition Of Capsaicin Responses By Cannabinoids CBG, CBD, THC And Their Combination In Cultured Sensory Neurons. Journal Of Pain Research, 14, 3603.

Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., ... & Friedman, D. (2014). Cannabidiol: Pharmacology And Potential Therapeutic Role In Epilepsy And Other Neuropsychiatric Disorders. Epilepsia, 55(6), 791-802.

De Oliveira, A. B., De Mello, M. T., Tufik, S., & Peres, M. F. P. (2019). Weight Loss And Improved Mood After Aerobic Exercise Training Are Linked To Lower Plasma Anandamide In Healthy People. Physiology & Behavior, 201, 191-197.

Gieringer, D., & Rosenthal, E. (2008). Marijuana Medical Handbook: A Practical Guide To Therapeutic Uses Of Marijuana. Quick Trading Company.

Greydanus, D. E., Hawver, E. K., Greydanus, M. M., & Merrick, J. (2013). Marijuana: Current Concepts. Frontiers In Public Health, 1, 42.

Navarro, G., Varani, K., Reyes-Resina, I., Sanchez De Medina, V., Rivas-Santisteban, R., Sanchez-Carnerero Callado, C., ... & Franco, R. (2018). Cannabigerol Action At Cannabinoid CB1 And CB2 Receptors And At CB1–CB2 Heteroreceptor Complexes. Frontiers In Pharmacology, 9, 632.

Nilius, B., Appendino, G., & Owsianik, G. (2012). The Transient Receptor Potential Channel TRPA1: From Gene To Pathophysiology. Pflügers Archiv-European Journal Of Physiology, 464(5), 425-458.